Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model

Neuropharmacology

Volumn 64, Issue , 2013, Pages 137-144

  Dobarro, Marta ^a   Orejana, Lourdes ^a   Aguirre, Norberto ^a   Ramírez, María Javier ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

A levels; Ageing; BACE1; Hippocampus; IDE; JNK1; SAMP8

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; INSULINASE; PROPRANOLOL; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TAU PROTEIN;

AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE;

ADRENERGIC BETA-ANTAGONISTS; AGING; AMYLOID NEUROPATHIES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MEMORY DISORDERS; MICE; MICE, INBRED STRAINS; NEURONAL PLASTICITY; NEURONS; NOOTROPIC AGENTS; PHOSPHORYLATION; PROPRANOLOL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RANDOM ALLOCATION; TAU PROTEINS; TAUOPATHIES;

EID: 84866419461     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.047     Document Type: Article

References (64)

1. B. Aisa, R. Tordera, B. Lasheras, J. Del Rio, and M.J. Ramirez Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats Psychoneuroendocrinology 32 2007 256 266
2. H. Akiyama, H. Kondo, K. Ikeda, M. Kato, and P.L. McGeer Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition Brain Res. 902 2001 277 281
3. P.V. Arriagada, J.H. Growdon, E.T. Hedley-Whyte, and B.T. Hyman Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease Neurology 42 1992 631 639
4. K.H. Ashe, and K.R. Zahs Probing the biology of Alzheimer's disease in mice Neuron 66 2010 631 645
5. Y.A. Barde Neurotrophic factors: an evolutionary perspective J. Neurobiol. 25 1994 1329 1333
6. N. Barzilai, G. Atzmon, C.A. Derby, J.M. Bauman, and R.B. Lipton A genotype of exceptional longevity is associated with preservation of cognitive function Neurology 67 2006 2170 2175
7. A. Bellucci, M.C. Rosi, C. Grossi, A. Fiorentini, I. Luccarini, and F. Casamenti Abnormal processing of tau in the brain of aged TgCRND8 mice Neurobiol. Dis. 27 2007 328 338
8. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403
9. U. Bodendorf, S. Danner, F. Fischer, M. Stefani, C. Sturchler-Pierrat, K.H. Wiederhold, M. Staufenbiel, and P. Paganetti Expression of human beta-secretase in the mouse brain increases the steady-state level of betaamyloid J. Neurochem. 80 2002 799 806
10. A.M. Canudas, J. Gutierrez-Cuesta, M.I. Rodríguez, D. Acuña-Castroviejo, F.X. Sureda, A. Camins, and M. Pallàs Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM) Mech. Ageing Dev. 126 2005 1300 1304
11. X.R. Cheng, Y. Yang, W.X. Zhou, and Y.X. Zhang Expression of VGLUTs contributes to degeneration and acquisition of learning and memory Neurobiol. Learn. Mem. 95 2011 361 375
12. J. Del Valle, J. Duran-Vilaregut, G. Manich, G. Casadesús, M.A. Smith, A. Camins, M. Pallàs, C. Pelegrí, and J. Vilaplana Early amyloid accumulation in the hippocampus of SAMP8 mice J. Alzheimers Dis. 19 2010 1303 1315
13. V. Dhikav, and K.S. Anand Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486) Med. Hypotheses 68 2007 1088 1092
14. A. Ennanceur, and J. Delacour A new one trial-test for neurobiological studies of memory in rats. 1: behavioral data Behav. Brain Res. 31 1988 47 59
15. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc. Natl. Acad. Sci. U S A 100 2003 4162 4167
16. O. Flores, H. Núñez, H. Pérez, C. Morgan, R. Soto-Moyano, L. Valladares, H. Burgos, R. Olivares, and A. Hernández beta-Adrenoceptor blockade depresses molecular and functional plasticities in the rat neocortex Brain Res. Bull. 82 2010 284 288
17. H. Fukumoto, B.S. Cheung, B.T. Hyman, and M.C. Irizarry Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease Arch. Neurol. 59 2002 1381 1389
18. S. García-Matas, J. Gutierrez-Cuesta, A. Coto-Montes, R. Rubio-Acero, C. Díez-Vives, A. Camins, M. Pallàs, C. Sanfeliu, and R. Cristòfol Dysfunction of astrocytes in senescence-accelerated mice SAMP8 reduces their neuroprotective capacity Aging Cell 7 2008 630 640
19. A.L. Guillozet, S. Weintraub, D.C. Mash, and M.M. Mesulam Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment Arch. Neurol. 60 2003 729 736
20. Z. Guo, M. Viitanen, B. Winblad, and L. Fratiglioni Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition J. Am. Geriatr. Soc. 47 1999 723 726
21. I. Hajjar, M. Keown, and B. Frost Antihypertensive agents for aging patients who are at risk for cognitive dysfunction Curr. Hypertens. 7 2005 466 473
22. H. Hamamoto, A. Honma, M. Irino, T. Matsushita, K. Toda, M. Matsumura, and T. Takeda Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM) Mech. Ageing Dev. 26 1984 91 102
23. C. Haas Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease J. Alzheimers Dis. 28 2012 241 281
24. L.B. Hoffman, J. Schmeidler, G.T. Lesser, M.S. Beeri, D.P. Purohit, H.T. Grossman, and V. Haroutunian Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons Neurology 72 2009 1720 1726
25. A.S. Khachaturian, P.P. Zandi, C.G. Lyketsos, K.M. Hayden, I. Skoog, M.C. Norton, J.T. Tschanz, L.S. Mayer, K.A. Welsh-Bohmer, and J.C. Breitner Antihypertensive medication use and incident Alzheimer disease: the Cache County Study Arch. Neurol. 63 2006 686 692
26. D. Kögel, R. Schomburg, E. Copanaki, and J.H. Prehn Regulation of gene expression by the amyloid precursor protein: inhibition of the JNK/cJun pathway Cell. Death Differ. 12 2005 1 9
27. B.V. Kumar, S.A. Farr, J.F. Flood, K. Vyas, M. Franko, W.A. Banks, and J.E. Morley Site directed antisense oligonucleotides decrease the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice Peptides 21 2000 1769 1775
28. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Lett. 345 1994 33 37
29. J.M. Kyriakis Making the connection: coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses Biochem. Soc. Symp. 64 1999 29 48
30. Q. Li, H.F. Zhao, Z.F. Zhang, Z.G. Liu, X.R. Pei, J.B. Wang, and Y. Li Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus Neuroscience 163 2009 741 749
31. W. Liu, C. Liu, J. Zhu, P. Shu, B. Yin, Y. Gong, B. Qiang, J. Yuan, and X. Peng MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice Neurobiol. Aging 33 2010 522 534
32. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 2005 545 551
33. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, P. Denis, W. Fan, H. Kha, J. Zhang, Y. Gong, L. Martin, J.C. Louis, Q. Yan, W.G. Richards, M. Citron, and R. Vassar Mice deficient in BACE1, the Alzheimer's betasecretase, have normal phenotype and abolished beta-amyloid generation Nat. Neurosci. 4 2001 231 232
34. J. Maruyama, I. Naguro, K. Takeda, and H. Ichijo Stress-activated MAP kinase cascades in cellular senescence Curr. Med. Chem. 16 2009 1229 1235
35. J.R. McDermott, and A.M. Gibson Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochem. Res. 22 1997 49 56
36. P.D. Mehta Amyloid beta protein as a marker or risk factor of Alzheimer's disease Curr. Alzheimer Res. 4 2007 359 363
37. J.S. Miners, Z. Van Helmond, K. Chalmers, G. Wilcock, S. Love, and P.G. Kehoe Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy J. Neuropathol. Exp. Neurol. 65 2006 1012 1021
38. J.E. Morley, V.B. Kumar, A.E. Bernardo, S.A. Farr, K. Uezu, N. Tumosa, and J.F. Flood Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory Peptides 21 2000 1761 1767
39. A.H. Nagahara, and M.H. Tuszynsk Potential therapeutic uses of BDNF in neurological and psychiatric disorders Nat. Rev. Drug Discov. 10 2011 209 219
40. L. Orejana, L. Barros-Miñones, J. Jordán, E. Puerta, and N. Aguirre Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model Neurobiol. Aging 33 2012 625.e11-20
41. M. Pallas, A. Camins, M.A. Smith, G. Perry, H.G. Lee, and G. Casadesus From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8) J. Alzheimers Dis. 15 2008 615 624
42. K.C.H. Pang, J.P. Miller, A. Fortress, and D. McAuley Age-related disruptions of circadian rhythm and memory in the senescence-accelerated mouse (SAM8) Age 28 2006 283 296
43. A.G. Pearson, U.T. Byrne, G.A. MacGibbon, R.L. Faull, and M. Dragunow Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains Neurosci. Lett. 398 2006 246 250
44. E. Pimenta, and S. Oparil Management of hypertension in the elderly Nat. Rev. Cardiol. 9 2012 286 296
45. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh, and D.J. Selkoe Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation J. Biol. Chem. 273 1998 32730 32738
46. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB J. 22 2007 659 661
47. B. Roozendaal, E.L. Hahn, S.V. Nathan, D.J. de Quervain, and J.L. McGaugh Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala J. Neurosci. 24 2004 8161 8169
48. R. Russo, R. Borghi, W. Markesbery, M. Tabaton, and A. Piccini Neprylisin decreases uniformly in Alzheimer's disease and in normal aging FEBS Lett. 579 2005 6027 6030
49. G. Sabio, M. Das, A. Mora, Z. Zhang, J.Y. Jun, H.J. Ko, T. Barret, J.K. Kim, and R.J. Davis A stress signaling pathway in adipose tissue regulates hepatic insulin resistance Science 322 2008 1539 1543
50. G.J. Siegel, and N.B. Chauhan Neurotrophic factors in Alzheimer's and Parkinson's disease brain Brain Res. Rev. 33 2000 199 227
51. F.X. Sureda, J. Gutierrez-Cuesta, M. Romeu, M. Mulero, A.M. Canudas, A. Camins, J. Mallol, and M. Pallàs Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8 Exp. Gerontol. 41 2006 360 367
52. M. Tajes, J. Gutierrez-Cuesta, J. Folch, D. Ortuño-Sahagun, E. Verdaguer, A. Jiménez, F. Junyent, A. Lau, A. Camins, and M. Pallàs Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8) Exp. Gerontol. 45 2010 702 710
53. T. Takeda Senescence-accelerated mouse (SAM): a biogerontological resource in aging research Neurobiol. Aging 20 1999 105 110
54. T. Takeda, M. Hosokawa, K. Higuchi, M. Hosono, I. Akiguchi, and H. Katoh A novel murine model of aging, Senescence-Accelerated Mouse (SAM) Arch. Gerontol. Geriatr. 19 1994 185 192
55. T. Takeda, M. Hosokawa, S. Takeshita, M. Irino, K. Higuchi, T. Matsushita, Y. Tomita, K. Yasuhira, H. Hamamoto, K. Shimizu, M. Ishii, and T. Yamamuro A new murine model of accelerated senescence Mech. Ageing Dev. 17 1981 183 194
56. E. Tamagno, M. Guglielmotto, L. Giliberto, A. Vitali, R. Borghi, R. Autelli, O. Danni, and M. Tabaton JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 Neurobiol. Aging 30 2009 1563 1573
57. E. Tamagno, M. Parola, P. Bardini, A. Piccini, R. Borghi, M. Guglielmotto, G. Santoro, A. Davit, O. Danni, M.A. Smith, G. Perry, and M. Tabaton Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways J. Neurochem. 92 2005 628 636
58. N. Tartaglia, J. Du, W.J. Tyler, E. Neale, L. Pozzo-Miller, and B. Lu Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor J. Biol. Chem. 276 2001 37585 37593
59. K. Tomobe, and Y. Nomura Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence Neurochem. Res. 34 2009 660 669
60. F. Valtorta, M. Pennuto, D. Bonanomi, and F. Benfenati Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays 26 2004 445 453
61. L.P. van der Heide, G.M. Ramakers, and M.P. Smidt Insulin signaling in the central nervous system: learning to survive Prog. Neurobiol. 79 2006 205 221
62. K. Vekrellis, Z. Ye, W.Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M.R. Rosner, and D.J. Selkoe Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J. Neurosci. 20 2000 1657 1665
63. F. Wang, C. Shu, L. Jia, X. Zuo, Y. Zhang, A. Zhou, W. Qin, H. Song, C. Wei, F. Zhang, Z. Hong, M. Tang, D.M. Wang, and J. Jia Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese Neurobiol. Aging 33 2010 1 9
64. J. Wang, L. Ho, L. Chen, Z. Zhao, W. Zhao, X. Qian, N. Humala, I. Seror, S. Bartholomew, C. Rosendorff, and G.M. Pasinetti Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease J. Clin. Invest. 117 2007 3393 3402